Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter ...

Immunotherapies, especially CAR T-cell therapy, have fundamentally changed cancer treatment in recent years, particularly for ...

Immunotherapy, which uses a patient's immune system to treat disease, has increased survival for some adults and children ...

Explore new St. Jude research finding how removing the immune response “brake” gene ZMYND8 led to better control of solid tumors and chronic viral infections.

Chronic lymphocytic leukemia has long been one of the most stubborn targets for chimeric antigen receptor T cell therapy, a ...

Using microscopic silicon nanowires, Singh and his team delivered the instructions into more than 90% of aging T cells without damaging them. The goal wasn't to reverse aging. It was to restore enough ...

Metabolism guides the activation states of regulatory T cells, the immune cells that prevent inappropriate activation of the immune system. St. Jude Children's Research Hospital scientists recently ...

A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health have discovered how the ...